| http://www.w3.org/ns/prov#value | - BEVERLY, MA--(Marketwire - February 04, 2013) - Cellceutix Corporation (OTCBB: CTIX) (the Company), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, today announces that the Company is submitting an abstract for the upcoming 2013 American Society of Clinical Oncology
|
